Overview

Opioid Prescription After Cesarean Trial

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Non-inferiority randomized trial of 5,500 women with a cesarean delivery randomized prior to discharge to either an individualized opioid prescription protocol (IOPP) that includes shared decision making or to a fixed opioid prescription of 20 tablets of oxycodone 5mg.
Phase:
Phase 3
Details
Lead Sponsor:
The George Washington University Biostatistics Center
Treatments:
Analgesics, Opioid
Oxycodone